Her research interests lie in advancing research on the role of mitochondrial gene variants in the risk for, and phenomenology of, neuropsychiatric disorders. Her research portfolio also includes pharmacogenetic studies focusing on the mitochondrial system. Her findings are very translatable into important medical improvements, such as new biomarkers, reduced side effects/ medication failure, enhanced diagnostics, and better therapies for psychiatric patients.